Tekturna Shows Non-Inferiority To Merck’s Cozaar On Left Ventricular Hypertrophy
This article was originally published in The Pink Sheet Daily
Executive Summary
Combination of both medicines, however, did not achieve a statistically significant reduction in LVH over losartan alone.